In this episode of the Diabetes Innovators Series, Scott Hebl, Vice
President for Program Management at Medtronic, discusses the exciting
innovations and future of the MiniMed brand following its separation from
Medtronic. He highlights the importance of simplifying diabetes management
through advanced technology, including artificial intelligence and
user-friendly devices. Scott shares his personal journey with medical
devices and his passion for improving patient care.
Chapters
00:00 The Excitement of Innovation in Diabetes Care
02:05 Future Innovations and Technology in Diabetes Management
06:03 Insights from the Scientific Sessions
08:19 Personal Journey and Passion for Medical Devices
Resources:
Medtronic
Scott Hebl LinkedIn